Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC

Clinical trial NCT03611738 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03611738
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Lung Cancer Non-small Cell Lung Cancer Metastatic Non-small Cell Lung Cancer Stage IIIB Stage IV Non-small Cell Lung Cancer EGFR Negative Non-Small Cell Lung Cancer

Start date: 2019-02-01
Primary completion: 2025-04-28
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.